Indication
Malignant mesothelioma of pleura
Malignant mesothelioma of the pleura is an aggressive, rare cancer arising from the mesothelial cell lining of the chest wall and lungs. Read more about Malignant mesothelioma of pleura
27 drugs 24 manufacturers
Drugs that treat it
Common Malignant mesothelioma of pleura therapies.
PEMETREXED DISODIUM
PEMETREXED DISODIUM
PEMETREXED DISODIUM
PEMETREXED DISODIUM
PEMETREXED DISODIUM
PEMETREXED DISODIUM
AXTLE (pemetrexed dipotassium)
PEMETREXED
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMalignant mesothelioma of the pleura is an aggressive, rare cancer arising from the mesothelial cell lining of the chest wall and lungs.
It most commonly affects older adults with a history of occupational or environmental asbestos exposure, typically emerging after a latency period of several decades.
Pathophysiologically, inhaled fibers cause chronic inflammation, genetic damage, and diffuse tumor growth that encases the lung and invades adjacent thoracic structures.
Clinically, it is classified into epithelioid, sarcomatoid, or biphasic histologic subtypes and typically manifests with dyspnea, persistent nonpleuritic chest pain, and recurrent pleural effusions.
- cancer.gov
Malignant mesothelioma of the pleura is an aggressive, rare cancer arising from the mesothelial cell lining of the chest wall and lungs
- nih.gov
Malignant mesothelioma of the pleura is an aggressive, rare cancer arising from the mesothelial cell lining of the chest wall and lungs Pathophysiologically, inhaled fibers cause chronic inflammation, genetic damage, and diffuse tumor growth that encases the lung and invades adjacent thoracic structures Clinically, it is classified into epithelioid, sarcomatoid, or biphasic histologic subtypes and typically manifests with dyspnea, persistent nonpleuritic chest pain, and recurrent pleural effusio...
- clevelandclinic.org
Malignant mesothelioma of the pleura is an aggressive, rare cancer arising from the mesothelial cell lining of the chest wall and lungs
- nih.gov
It most commonly affects older adults with a history of occupational or environmental asbestos exposure, typically emerging after a latency period of several decades Clinically, it is classified into epithelioid, sarcomatoid, or biphasic histologic subtypes and typically manifests with dyspnea, persistent nonpleuritic chest pain, and recurrent pleural effusions
- nih.gov
It most commonly affects older adults with a history of occupational or environmental asbestos exposure, typically emerging after a latency period of several decades Pathophysiologically, inhaled fibers cause chronic inflammation, genetic damage, and diffuse tumor growth that encases the lung and invades adjacent thoracic structures
- cancer.gov
Clinically, it is classified into epithelioid, sarcomatoid, or biphasic histologic subtypes and typically manifests with dyspnea, persistent nonpleuritic chest pain, and recurrent pleural effusions
- cancer.gov
Clinically, it is classified into epithelioid, sarcomatoid, or biphasic histologic subtypes and typically manifests with dyspnea, persistent nonpleuritic chest pain, and recurrent pleural effusions
Personalize your experience
Follow Malignant mesothelioma of pleura and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.